Virtus ETF Advisers’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $333K | Sell |
|
|||||
|
2024
Q3 | $309K | Hold |
|
|||||
|
2024
Q2 | $326K | Buy |
|
|||||
|
2024
Q1 | $310K | Buy |
|
|||||
|
2023
Q4 | $333K | Buy |
|
|||||
|
2023
Q3 | $252K | Sell |
|
|||||
|
2023
Q2 | $342K | Buy |
|
|||||
|
2023
Q1 | $298K | Buy |
|
|||||
|
2022
Q4 | $303K | Sell |
|
|||||
|
2022
Q3 | $279K | Buy |
|
|||||
|
2022
Q2 | $246K | Sell |
|
|||||
|
2022
Q1 | $348K | Hold |
|
|||||
|
2021
Q4 | $402K | Buy |
|
|||||
|
2021
Q3 | $181K | Sell |
|
|||||
|
2021
Q2 | $387K | Sell |
|
|||||
|
2021
Q1 | $671K | Buy |
|
|||||
|
2020
Q4 | $568K | Buy |
|
|||||
|
2020
Q3 | $342K | Buy |
|
|||||
|
2020
Q2 | $445K | Sell |
|
|||||
|
2020
Q1 | $623K | Sell |
|
|||||
|
2019
Q4 | $756K | Sell |
|
|||||
|
2019
Q3 | $846K | Sell |
|
|||||
|
2019
Q2 | $829K | Buy |
|
|||||
|
2019
Q1 | $649K | Buy |
|
|||||
|
2018
Q4 | $574K | Sell |
|
|||||
|
2018
Q3 | $1.05M | Buy |
|
|||||
|
2018
Q2 | $682K | Sell |
|
|||||
|
2018
Q1 | $800K | Sell |
|
|||||
|
2017
Q4 | $974K | Buy |
|
|||||
|
2017
Q3 | $947K | Hold |
|
|||||
|
2017
Q2 | $1.1M | Sell |
|
|||||
|
2017
Q1 | $1.23M | Buy |
|
|||||
|
2016
Q4 | $964K | Buy |
|
|||||
|
2016
Q3 | $1.01M | Buy |
|
|||||
|
2016
Q2 | $552K | Sell |
|
|||||
|
2016
Q1 | $709K | Buy |
|